首颐医疗药师端
Published by:
SHOUYI HEALTHCARE INVESTMENTLTD
Description
首颐医疗药师端APP为药师提供移动办公，支持线上审方等功能。
Screenshots
首颐医疗药师端 FAQ
-
Is 首颐医疗药师端 free?
Yes, 首颐医疗药师端 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 首颐医疗药师端 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 首颐医疗药师端 cost?
首颐医疗药师端 is free.
-
What is 首颐医疗药师端 revenue?
To get estimated revenue of 首颐医疗药师端 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in United States yet.
Ratings History
首颐医疗药师端 Reviews
No Reviews in United States
App doesn't have any reviews in United States yet.
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
首颐医疗药师端 Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
国药医生
国药医生
|
Unlock
|
Unlock
|
0
|
|
9 months ago | |
西苑医院（医生版）
|
Unlock
|
Unlock
|
0
|
|
5 months ago | |
广东云医院药师端
|
Unlock
|
Unlock
|
0
|
|
7 months ago | |
国药医生医护端
N/A
|
Unlock
|
Unlock
|
0
|
|
2 weeks ago | |
国药医生药师端
|
Unlock
|
Unlock
|
0
|
|
3 months ago | |
无锡精卫医生
N/A
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
东莞东华药师版
|
Unlock
|
Unlock
|
0
|
|
7 months ago | |
醴陵市中医院-医生版
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
191药交易
药品批件药厂转让药品招商医药资讯平台
|
Unlock
|
Unlock
|
0
|
|
7 months ago |
首颐医疗药师端 Installs
Last 30 days
首颐医疗药师端 Revenue
Last 30 days首颐医疗药师端 Revenue and Downloads
Gain valuable insights into 首颐医疗药师端 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- SHOUYI HEALTHCARE INVESTMENTLTD
- Languages
- Chinese
- Recent release
- 86.0.0 (1 year ago )
- Released on
- Mar 8, 2022 (2 years ago )
- Also available in
- Pakistan , Italy , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , India , Poland , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Denmark , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , China , Colombia , Czechia , Germany , United Arab Emirates , Dominican Republic , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel
- Last Updated
- 5 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.